Tenascin-C fragments induce aggrecanase activity in cartilage

Tenascin-C fragments induce aggrecanase activity in cartilage

Dettagli Bibliografici
Autori principali:	Sofat, N, Nagase, H
Natura:	Conference item
Pubblicazione:	2008

Documenti analoghi

Proteolytic fragments of tenascin-C promote cartilage degradation
di: Sofat, N, et al.
Pubblicazione: (2010)

Proteolytic fragments of fibronectin containing the type III-13 and III-14 repeats induce aggrecanase activity in cartilage
di: Sofat, N, et al.
Pubblicazione: (2006)

Tenascin-C fragments are endogenous inducers of cartilage matrix degradation.
di: Sofat, N, et al.
Pubblicazione: (2012)

Tenascin-C fragments are endogenous inducers of cartilage matrix degradation
di: Sofat, N, et al.
Pubblicazione: (2011)

Aggrecanases in cartilage matrix breakdown
di: Nagase, H
Pubblicazione: (2001)

Aggrecanases and cartilage matrix degradation.
di: Nagase, H, et al.
Pubblicazione: (2003)

Fibronectin fragments induce aggrecan degradation in human cartilage and are increased in osteoarthritic cartilage
di: Sofat, N, et al.
Pubblicazione: (2007)

Isolation of fibronectin fragments that induce aggrecan degradation in cartilage
di: Sofat, N, et al.
Pubblicazione: (2006)

Collagenases and aggrecanases: understanding the role of non-catalytic domains in cartilage matrix breakdown
di: Nagase, H, et al.
Pubblicazione: (2005)

THE TYPE III 8-10 REPEATS OF FIBRONECTIN INDUCE AGGRECANASE ACTIVITY VIA ALPHA5BETA1 INTEGRIN AND THE TYPE III 13-14 REPEATS ACT VIA TLR 4 RECEPTORS
di: Sofat, N, et al.
Pubblicazione: (2009)

The type III 8-10 repeats of fibronectin induce aggrecanase activity via alpha(5)beta(1) integrin and type III 13-14 repeats act via TLR 4 receptors
di: Sofat, N, et al.
Pubblicazione: (2009)

Calcium pentosan polysulfate is a multi-functional aggrecanase inhibitor that enhances interaction with endogenous TIMP-3 in cartilage
di: Troeberg, L, et al.
Pubblicazione: (2009)

TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors.
di: Gendron, C, et al.
Pubblicazione: (2003)

TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).
di: Kashiwagi, M, et al.
Pubblicazione: (2001)

Elucidating the function of non catalytic domains of collagenases and aggrecanases.
di: Nagase, H, et al.
Pubblicazione: (2008)

Elucidating the function of non catalytic domains of collagenases and aggrecanases
di: Nagase, H, et al.
Pubblicazione: (2008)

Aggrecanases and TIMP-3 in osteoarthritis: structure, function and in vivo challenges
di: Nagase, H
Pubblicazione: (2009)

Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage
di: Flannery Carl R, et al.
Pubblicazione: (2011-07-01)

Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
di: Sawaji, Y, et al.
Pubblicazione: (2008)

Screening for selective aggrecanase substrates to detect early proteolytic events in cartilage degradation
di: Fowkes, M, et al.
Pubblicazione: (2018)

Coculture of bovine cartilage with synovium and fibrous joint capsule increases aggrecanase and matrix metalloproteinase activity
di: Swärd, Per, et al.
Pubblicazione: (2017)

Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity
di: Lo Cicero, A, et al.
Pubblicazione: (2012)

Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity.
di: Lo Cicero, A, et al.
Pubblicazione: (2012)

Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.
di: Troeberg, L, et al.
Pubblicazione: (2008)

Aggrecan breakdown in cartilage induced by proteolytic fragments of fibronectin: implications in osteoarthritis
di: Nagase, H
Pubblicazione: (2009)

Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.
di: Maingot, L, et al.
Pubblicazione: (2013)

Mannosamine inhibits aggrecanase-mediated degradation of the mechanically functional portion of proteoglycans and of the physical properties of articular cartilage
di: Patwari, Parth, 1972-
Pubblicazione: (2014)

Tenascin-C suppresses Rho activation.
di: Wenk, M, et al.
Pubblicazione: (2000)

Androgen receptor variant-7 regulation by tenascin-c induced src activation
di: Rintu Thomas, et al.
Pubblicazione: (2022-08-01)

Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.
di: Midwood, K, et al.
Pubblicazione: (2009)

Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation.
di: Nuti, E, et al.
Pubblicazione: (2013)

Tenascin-C at a glance
di: Midwood, K, et al.
Pubblicazione: (2016)

Advances in tenascin-C biology.
di: Midwood, K, et al.
Pubblicazione: (2011)

Tenascin C in Lung Diseases
di: Chantal Donovan, et al.
Pubblicazione: (2023-01-01)

Tenascin-C as a cardiovascular marker
di: A. M. Alieva, et al.
Pubblicazione: (2022-09-01)

Aggrecanase-selective tissue inhibitor of metalloproteinase-3 (TIMP3) protects articular cartilage in a surgical mouse model of osteoarthritis
di: Hiroyuki Nakamura, et al.
Pubblicazione: (2020-06-01)

Tenascin-C in betel-quid associated lesions
di: Zain, R.B., et al.
Pubblicazione: (1999)

Calcium pentosan polysulfate increases affinity between aggrecanases (ADAMTS-4 and-5) and TIMP-3 by a conformational change
di: Troeberg, L, et al.
Pubblicazione: (2010)

Expression and immune function of tenascin-C.
di: Udalova, I, et al.
Pubblicazione: (2011)

Regulation of fibroblast migration by tenascin-C.
di: Trebaul, A, et al.
Pubblicazione: (2007)